(44- 20) 74 18 84 00 Fax (44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http: // www. emea. europa. eu ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged мозък произвежда твърде много клетки), включващи близо 3 000 пациента с ET.
Die Wirkungen von Xagrid wurden zunächst in Versuchsmodellen getestet, bevor sie an Menschen untersucht wurden.